1-20 of 80
Authors: Dan Atar
Save search
Sort by
Journal Article

Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy: A clinical consensus statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care (ACVC), European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Heart Rhythm Association (EHRA) of the ESC, the ESC Working Group on Cardiovascular Pharmacotherapy and the European Association for Haemophilia and Allied Disorders (EAHAD)

PDF
Dan Atar and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 11, Issue 3, May 2025, Pages 275–289, https://doi.org/10.1093/ehjcvp/pvaf006
Published: 26 March 2025
Journal Article

The NORwegian atrial fibrillation self-SCREENing (NORSCREEN) trial: rationale and design of a randomized controlled trial

PDF
Miroslav Boskovic and others
EP Europace, Volume 26, Issue 10, October 2024, euae228, https://doi.org/10.1093/europace/euae228
Published: 09 September 2024
Journal Article
EDITOR'S CHOICE

Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on Thrombosis

PDF
Bruna Gigante and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 7, November 2024, Pages 614–645, https://doi.org/10.1093/ehjcvp/pvae064
Published: 05 September 2024
Journal Article

Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials

PDF
Renate B Schnabel and others
European Heart Journal, Volume 45, Issue 46, 7 December 2024, Pages 4902–4916, https://doi.org/10.1093/eurheartj/ehae596
Published: 02 September 2024
Journal Article

Digital recruitment and compliance to treatment recommendations in the Norwegian Atrial Fibrillation self-screening pilot study

PDF
Edvard Liljedahl Sandberg and others
European Heart Journal - Digital Health, Volume 5, Issue 3, May 2024, Pages 371–378, https://doi.org/10.1093/ehjdh/ztae026
Published: 09 April 2024
Journal Article

Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines

PDF
Antonio Landi and others
European Heart Journal. Acute Cardiovascular Care, Volume 13, Issue 1, January 2024, Pages 173–180, https://doi.org/10.1093/ehjacc/zuad158
Published: 03 January 2024
Journal Article

The Danish-Norwegian randomized trial on beta-blocker therapy after myocardial infarction: Design, rationale, and baseline characteristics

PDF
Anna Meta Dyrvig Kristensen and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 3, April 2024, Pages 175–183, https://doi.org/10.1093/ehjcvp/pvad093
Published: 28 November 2023
Journal Article

Cardiac device infection: removing barriers to timely and adequate treatment

PDF
Dan Atar and others
European Heart Journal, Volume 44, Issue 35, 14 September 2023, Pages 3323–3326, https://doi.org/10.1093/eurheartj/ehad490
Published: 02 August 2023
Journal Article
EDITOR'S CHOICE

Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease

PDF
Marco Valgimigli and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 5, August 2023, Pages 462–496, https://doi.org/10.1093/ehjcvp/pvad032
Published: 29 April 2023
Journal Article

Fully digital self-screening for atrial fibrillation with patch electrocardiogram

PDF
Edvard Liljedahl Sandberg and others
EP Europace, Volume 25, Issue 5, May 2023, euad075, https://doi.org/10.1093/europace/euad075
Published: 22 March 2023
Journal Article
EDITOR'S CHOICE

Within and beyond 12-month efficacy and safety of antithrombotic strategies in patients with established coronary artery disease: two companion network meta-analyses of the 2022 joint clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), European Association for Acute CardioVascular Care (ACVC), and European Association of Preventive Cardiology (EAPC)

PDF
Eliano Pio Navarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 3, April 2023, Pages 271–290, https://doi.org/10.1093/ehjcvp/pvad016
Published: 03 March 2023
Journal Article

CODE-EHR best practice framework for the use of structured electronic healthcare records in clinical research

PDF
Dipak Kotecha and others
European Heart Journal, Volume 43, Issue 37, 1 October 2022, Pages 3578–3588, https://doi.org/10.1093/eurheartj/ehac426
Published: 29 August 2022
Journal Article

Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial

PDF
Raffaele De Caterina and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 3, May 2022, Pages 227–235, https://doi.org/10.1093/ehjcvp/pvaa140
Published: 28 December 2020
Journal Article

The perils of data sharing, meta-analyses, and estimating cardiovascular risk

PDF
Thomas A Marciniak and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages e55–e57, https://doi.org/10.1093/ehjcvp/pvaa109
Published: 17 September 2020
Journal Article

The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events

PDF
Dan Atar and others
EP Europace, Volume 22, Issue 2, February 2020, Pages 195–204, https://doi.org/10.1093/europace/euz292
Published: 20 November 2019
Journal Article

Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: A current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke Get access

PDF
Patrick Sulzgruber and others
European Heart Journal, Volume 40, Issue 36, 21 September 2019, Pages 3010–3012, https://doi.org/10.1093/eurheartj/ehz650
Published: 21 September 2019
Journal Article
EDITOR'S CHOICE

Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases

PDF
Gianluigi Savarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 2, March 2020, Pages 86–93, https://doi.org/10.1093/ehjcvp/pvz036
Published: 08 August 2019
Journal Article
EDITOR'S CHOICE

Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke

PDF
Patrick Sulzgruber and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 3, July 2019, Pages 171–180, https://doi.org/10.1093/ehjcvp/pvz016
Published: 23 May 2019
Journal Article

On-label reduced doses of non-vitamin K anticoagulants prove safe and efficient; yet how to ensure the correct dose for the right patient? Get access

PDF
Dan Atar and Irene Grundvold
European Heart Journal, Volume 40, Issue 19, 14 May 2019, Pages 1501–1503, https://doi.org/10.1093/eurheartj/ehz014
Published: 07 February 2019
Journal Article

Ivabradine for heart failure: regulatory differences in Europe and United States

PDF
Thomas A Marciniak and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 2, April 2019, Pages 119–121, https://doi.org/10.1093/ehjcvp/pvz006
Published: 01 February 2019